A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

NCT04131309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

NETWORK

Sponsor class

Conditions

Light Chain (AL) Amyloidosis, Stage 3B

Interventions

DRUG: Daratumumab
DRUG: Bortezomib Injection
DRUG: Dexamethasone oral tablet

Sponsor

Stichting European Myeloma Network

Collaborators

[object Object]